PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsEmmaus Life Sciences
Emmaus Life Sciences(EMMA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
EndariGlutamine2017-07-07
—
NutrestoreGlutamine2004-06-10
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Glutamine
pancreatic ductal carcinoma
,
pancreatic neoplasms
,
adenocarcinoma
,
colonic diverticulosis
,
fibrosis
,
cystic fibrosis
,
thalassemia
,
vaso-occlusive crises
,
sickle cell anemia
,
pharmacokinetics
,
sepsis
,
short bowel syndrome
,
hyperphagia
,
food diet and nutrition
,
genetic markers
Salicylic acid
peripheral arterial disease
,
hygiene
,
peripheral vascular diseases
,
arterial occlusive diseases
Alanine
non-small-cell lung carcinoma
Bevifimod
hypersensitivity
,
delayed hypersensitivity
Tribasic calcium phosphate
sickle cell anemia
,
thalassemia
Maltodextrin
sickle cell anemia
,
thalassemia
,
vaso-occlusive crises
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use